Our editorial published in this months JIM - @liverepi.bsky.social & colleagues identify MASLD in 18.1% of 28,000 middle-aged Swedish adults, define MASLD risk factors that translate into actionable advice for patients and identify risk with any alcohol use and possible deleterious effects of coffee
19.02.2026 16:57 β
π 1
π 1
π¬ 0
π 0
Delighted to share the evolution of @torchuk.bsky.social and our lessons learnt as a road map πΊοΈ π₯
Such a pleasure to work with talented colleagues across the UK to shape this and prime our project pipeline to improve outcomes in liver disease
doi.org/10.1136/flga...
#liversky #gastrosky #EVADE
09.02.2026 11:03 β
π 3
π 2
π¬ 1
π 0
Great article from Lazarus et al on the parallels today in the fight against MASLD with previous lessons learned from viral hepatitis
05.02.2026 20:44 β
π 1
π 1
π¬ 0
π 0
Our editorial in Hepatology about the FMO (fibrotic/ at-risk MASH in obesity) score. Developed to identify At-risk MASH. Validated in 4 external cohort. It uses ALT, AST, triglycerides and HDL and is able to rule-our At-risk MASH with a NPV of 0.97 and predicts LRE.
journals.lww.com/hep/citation...
15.12.2025 22:31 β
π 1
π 0
π¬ 0
π 0
I do hope there will be a prize for the nation with the biggest percentage of it's hospitals represented!
25.11.2025 22:14 β
π 1
π 0
π¬ 1
π 0
Traction building nicely across the π¬π§
Any help with spreading the word and getting hospital sites involved in your regions would be greatly appreciated ππΌ
We are folding in patient trajectory as a novel angle - should be interesting!
#liversky
25.11.2025 21:03 β
π 1
π 1
π¬ 0
π 0
Our paper published today in Frontline Gastro
18 months after introducing a decentralised Fibroscan service:
βPatient: 33 564 km and 16.1 days of travel saved.
βEnvironmental: 4929.4 kgCO2 of CO2 saved.
βHospital services: 167 hospital appointments saved (=Β£43,587).
fg.bmj.com/content/flga...
21.11.2025 11:01 β
π 0
π 0
π¬ 0
π 0